GSK plc | GSK
Healthcare•$97.64B
Article
On December 4, 2025 GSK Terminated Collaboration With IDEAYA Biosciences; GSK Will Transfer The Werner Helicase And Pol Theta Clinical Programs To The Co In Accordance With The Applicable Provisions Of The Agreement; IDEAYA Biosciences Will Evaluate Its Strategic Options For These Two Programs In 2026, And The Update Does Not Change Its Expectation Of Cash Runway Into 2030
Sentiment:5
View OriginalBenzinga•Dec 05, 2025•21:26
Corporate TransactionOperational UpdateSector Analysis
Benzinga•Dec 05, 2025•18:00
Expert OpinionSector Analysis
Article
AstraZeneca, GSK Among Executives Asked To Help Redesign UK Pricing Rules-Report
Sentiment:5
View OriginalBenzinga•Dec 03, 2025•17:24
Expert OpinionRegulatory/PolicySector Analysis
Article
Trump Administration Locks In Zero Tariffs On UK Pharmaceuticals As NHS To Pay More For US Drugs
Sentiment:5
View OriginalBenzinga•Dec 02, 2025•09:02
Breaking News/EventRegulatory/PolicySector Analysis
Overview for GSK
Price chart and key metrics will appear here.